All lobbying filings

THE KPM GROUP DC LLC

Lobbying for SOLENO THERAPEUTICS, INC. · Soleno is focused on development of novel therapeutics for treatment of rare diseases.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $50,000.00 income · posted Apr 21, 2025

Official filing document

Bills named in this filing 6

HR 946
ORPHAN Cures Act
HR 1262
Mikaela Naylon Give Kids a Chance Act
S 932
Give Kids a Chance Act of 2025
HR 1414
Cameron’s Law
HR 1509
Accelerating Kids’ Access to Care Act of 2025
S 752
Accelerating Kids’ Access to Care Act

Lobbying activity 1

Health Issues

H.R.946, Optimizing Research Progress Hope And New (ORPHAN) Cures Act H.R.1262/S.932, Give Kids a Chance Act H.R.1414, Camerons Law H.R.1509/S.752, Accelerating Kids Access to Care Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.